Ameriprise Financial Inc Kodiak Sciences Inc. Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 33,628 shares of KOD stock, worth $89,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,628

Previous 45,263 25.71%

Holding current value

$89,450

Previous $238,000 66.81%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.48 $26,644 - $52,124	-11,635 Reduced 25.71%	33,628 $79,000
Q1 2024 May 15, 2024	BUY	$3.01 - $7.45 $35,021 - $86,680	11,635 Added 34.6%	45,263 $238,000
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $17,441 - $40,363	12,458 Added 58.85%	33,628 $102,000
Q3 2023 Nov 14, 2023	SELL	$1.8 - $7.49 $476,253 - $1.98 Million	-264,585 Reduced 92.59%	21,170 $38,000
Q2 2023 Aug 14, 2023	BUY	$4.3 - $9.48 $1.13 Million - $2.5 Million	263,258 Added 1170.19%	285,755 $1.97 Million
Q1 2023 May 15, 2023	SELL	$4.81 - $8.88 $15,680 - $28,948	-3,260 Reduced 12.66%	22,497 $139,000
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.05 $70,246 - $86,730	10,774 Added 71.91%	25,757 $184,000
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $113,421 - $187,287	14,983 New	14,983 $116,000
Q1 2020 May 15, 2020	SELL	$38.18 - $73.95 $1.01 Million - $1.96 Million	-26,572 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.9 - $76.65 $369,350 - $2.04 Million	26,572 New	26,572 $1.91 Million

Others Institutions Holding KOD

# of Institutions

104

Shares Held

39.8M

Call Options Held

7.6K

Put Options Held

3.5K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $138M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Kodiak Sciences Inc. Transaction History